Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.1 - $10.41 $22.6 Million - $38.6 Million
-3,707,900 Reduced 96.02%
153,700 $1.07 Million
Q1 2024

May 15, 2024

BUY
$7.77 - $10.61 $17.9 Million - $24.5 Million
2,304,800 Added 148.05%
3,861,600 $41 Million
Q4 2023

Feb 14, 2024

BUY
$6.53 - $8.23 $9.09 Million - $11.5 Million
1,391,800 Added 843.52%
1,556,800 $12.5 Million
Q3 2023

Nov 14, 2023

SELL
$7.69 - $9.71 $4.43 Million - $5.59 Million
-575,700 Reduced 77.72%
165,000 $1.36 Million
Q2 2023

Aug 14, 2023

SELL
$5.72 - $8.8 $4.83 Million - $7.43 Million
-843,800 Reduced 53.25%
740,700 $5.93 Million
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $1.6 Million - $2.52 Million
255,500 Added 19.22%
1,584,500 $12.8 Million
Q4 2022

Feb 14, 2023

SELL
$6.09 - $7.93 $9.48 Million - $12.3 Million
-1,556,800 Reduced 53.95%
1,329,000 $8.35 Million
Q3 2022

Nov 14, 2022

BUY
$4.58 - $9.21 $10.7 Million - $21.5 Million
2,330,800 Added 419.96%
2,885,800 $19.9 Million
Q2 2022

Aug 15, 2022

SELL
$7.06 - $23.63 $1.02 Million - $3.41 Million
-144,200 Reduced 20.62%
555,000 $4.64 Million
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $4.83 Million - $6.22 Million
223,700 Added 47.05%
699,200 $16 Million
Q4 2021

Feb 11, 2022

BUY
$23.0 - $29.01 $4.04 Million - $5.09 Million
175,500 Added 58.5%
475,500 $13.1 Million
Q3 2021

Nov 12, 2021

BUY
$25.04 - $30.06 $2.61 Million - $3.13 Million
104,200 Added 53.22%
300,000 $8.36 Million
Q2 2021

Aug 16, 2021

BUY
$27.43 - $32.7 $3.48 Million - $4.15 Million
126,800 Added 183.77%
195,800 $5.74 Million
Q1 2021

May 17, 2021

SELL
$21.37 - $34.38 $128,220 - $206,280
-6,000 Reduced 8.0%
69,000 $2.19 Million
Q2 2019

Aug 13, 2019

BUY
$20.52 - $26.45 $1.54 Million - $1.98 Million
75,000 New
75,000 $1.89 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.78B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.